Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT01941732 |
Date of registration:
|
10/09/2013 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Motor Response to Sildenafil in PD
|
Scientific title:
|
Motor Response to Acute Challenge to Sildenafil in Parkinsons Disease |
Date of first enrolment:
|
November 2003 |
Target sample size:
|
8 |
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT01941732 |
Study type:
|
Interventional |
Study design:
|
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
|
Phase:
|
Phase 4
|
|
Countries of recruitment
|
Denmark
| | | | | | | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Men
- Parkinsons disease
- Erectile dysfunction
- previous tried sildenafil with beneficial effects on motor function
Exclusion Criteria:
- psychosis
- Heart disease
Age minimum:
18 Years
Age maximum:
80 Years
Gender:
Male
|
Health Condition(s) or Problem(s) studied
|
Erectile Dysfunction
|
Parkinsons Disease
|
Intervention(s)
|
Drug: Sildenafil
|
Primary Outcome(s)
|
Motor function
[Time Frame: 1 hour]
|
Secondary Outcome(s)
|
Cerebral Blood Flow (rCBF)
[Time Frame: 1 hour]
|
Secondary ID(s)
|
VIA-Pilot1
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|